IDEXX Laboratories Director Sells $602,016 in Stock (IDXX)
IDEXX Laboratories (NASDAQ:IDXX) Director Thomas Craig unloaded 4,800 shares of the company’s stock on the open market in a transaction dated Wednesday, February 19th. The shares were sold at an average price of $125.42, for a total transaction of $602,016.00. Following the completion of the transaction, the director now directly owns 11,976 shares of the company’s stock, valued at approximately $1,502,030. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.
IDEXX Laboratories (NASDAQ:IDXX) traded down 0.98% during mid-day trading on Friday, hitting $125.09. The stock had a trading volume of 76,588 shares. IDEXX Laboratories has a one year low of $81.57 and a one year high of $126.83. The stock’s 50-day moving average is $114.6 and its 200-day moving average is $105.. The company has a market cap of $6.500 billion and a P/E ratio of 36.30.
IDEXX Laboratories (NASDAQ:IDXX) last announced its earnings results on Tuesday, February 4th. The company reported $0.82 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.81 by $0.01. The company had revenue of $354.10 million for the quarter, compared to the consensus estimate of $347.08 million. During the same quarter last year, the company posted $0.78 earnings per share. IDEXX Laboratories’s revenue was up 10.8% compared to the same quarter last year. Analysts expect that IDEXX Laboratories will post $3.83 EPS for the current fiscal year.
IDXX has been the subject of a number of recent research reports. Analysts at Canaccord Genuity raised their price target on shares of IDEXX Laboratories from $99.00 to $116.00 in a research note on Wednesday, February 5th. Analysts at Feltl & Co. downgraded shares of IDEXX Laboratories from a “hold” rating to a “sell” rating in a research note on Thursday, January 30th.
IDEXX Laboratories, Inc develops, manufactures and distributes products and provides services primarily for the companion animal veterinary, livestock and poultry, water testing and dairy markets.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.